研究和伦理委员会研究和伦理委员会.

Same author

FDA Expanded Access Programs for Experimental Medicines.

JAMA·2015

Same author

Scientific publication and global security.

JAMA·2011

Same author

Emergency Use Authorization (EUA) to enable use of needed products in civilian and military emergencies, United States.

Emerging infectious diseases·2008

Same author

Off-label use of prescription drugs.

American family physician·2003

Same author

The Food and Drug Administration's role in the protection of human subjects.

IRB·1983

Same author

Protecting human research subjects and the public: the role of FDA disqualification of clinical investigators.

Food, drug, cosmetic law journal·1980

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

相关实验视频

研究和伦理委员会研究和伦理委员会.

相关概念视频

FDA Expanded Access Programs for Experimental Medicines.

Scientific publication and global security.

Emergency Use Authorization (EUA) to enable use of needed products in civilian and military emergencies, United States.

Off-label use of prescription drugs.

The Food and Drug Administration's role in the protection of human subjects.

Protecting human research subjects and the public: the role of FDA disqualification of clinical investigators.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

相关实验视频

研究和伦理委员会研究和伦理委员会.

相关概念视频

相关文章

FDA Expanded Access Programs for Experimental Medicines.

Scientific publication and global security.

Emergency Use Authorization (EUA) to enable use of needed products in civilian and military emergencies, United States.

Off-label use of prescription drugs.

The Food and Drug Administration's role in the protection of human subjects.

Protecting human research subjects and the public: the role of FDA disqualification of clinical investigators.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.